We believe that sharing best in class medical device possibilities, clinical studies and professional achievements is helpful to all SCENAR® enthusiasts that follow us on Facebook.
Here is the article “TREATMENT OF CHRONIC PLANTAR FASCIITIS WITH NONINVASIVE INTERACTIVE NEUROSTIMULATION: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY” by a group of MD researchers from Italy (https://pubmed.ncbi.nlm.nih.gov/28633774/).
The initial treatment of plantar fasciitis should be conservative, with most cases responding to standard physiotherapy, nonsteroidal anti-inflammatory drugs (NSAIDs), heel pads, and stretching. In cases of chronic refractory symptoms, more invasive treatment could be necessary. Noninvasive interactive neurostimulation (NIN) is a form of electric therapy that works by locating areas of lower skin impedance. The objective of the present prospective randomized controlled study was to evaluate whether the use of NIN using the InterX 5002 (device manufactured under SCENAR® license) for chronic plantar fasciitis could result in greater improvement in a foot functional score, lower levels of reported pain, reduced patient consumption of NSAIDs, and greater patient satisfaction compared with electric shockwave therapy in patients without a response to standard conservative treatment.
The study showed superior results with NIN using the InterX 5002 in terms of the functional score, pain improvement, and daily intake of NSAIDs. The treatment of chronic plantar fasciitis was effective, with full patient satisfaction in >90% of cases.
Full Article: https://pubmed.ncbi.nlm.nih.gov/28633774/
